Overview

This trial is active, not recruiting.

Conditions patient satisfaction, patient preference
Sponsor Hospital Pharmacy of North Norway Trust
Collaborator University of Tromso
Start date March 2010
End date July 2010
Trial size 4 participants
Trial identifier NCT01131715, SHAN-002

Summary

A pharmacist follow-up procedure is under development. Patients with coronary heart disease (CHD) is being followed up by a pharmacist for one year with three meetings; at discharge from hospital, after three months and after one year. The evaluation is basically based on quantitative measures as achievement of therapeutic goals, number of drug related problems detected, hospitalisations etc. However, the patients' own experience with the follow-up procedure cannot be evaluated using these measures. Thus, a qualitative approach is needed. In this study, a total of four patients participating in the follow-up will be included and interviewed. A semistructured interview guide will be used. Interviews will be taped, transcribed and analyzed with the intention to explore how patients experience the follow-up from the pharmacist. A thoruough content analysis will be performed. Patients included must have met the pharmacist at least twice. The pharmacist in charge of the follow-up will recruit patients and hand out study information. Patients will reply to the principal investigator of the study and thus kept anonymous for the pharmacist in charge of the follow-up. No pressure will be put on the patients to join, but it will be emphasized that it will help evaluating the procedure.

United States No locations recruiting
Other Countries No locations recruiting

Primary Outcomes

Measure
Qualitative evaluation of the impact of pharmacist follow-up via interviews with the participating patients
time frame: 3 months or 1 year

Eligibility Criteria

Male or female participants from 18 years up to 80 years old.

Inclusion Criteria: - must have met the pharmacist at least twice - living within the area of Tromsoe city so that interviews are possible Exclusion Criteria - none as patients are already enrolled in another study

Additional Information

Official title Pharmacist Follow-up of Patients With Coronary Heart Disease. A Qualitative Study of Patient Experience.
Principal investigator Lars Smaabrekke, PhD
Trial information was received from ClinicalTrials.gov and was last updated in May 2010.
Information provided to ClinicalTrials.gov by Hospital Pharmacy of North Norway Trust.